PAPSS2 and inflammatory bowel disease: Our analysis of transcriptomic data from the FAH-SYSU, HMP and GSE83687 cohorts indicated a significant decrease in colonic papss2 gene expression in actively inflamed CD patients compared to non-disease and non-IBD controls (Fig. 7L).